ConsumerAnalysis: Beam cut on valuation callApr. 01, 2014 7:57 AM ETBeam Therapeutics Inc. (BEAM) StockBEAM-OLDBy: Clark Schultz, SA News Editor Stifel Nicolaus cuts its rating on Beam (NYSE:BEAM) to Hold from Buy on a valuation call. Shares of BEAM are up 22.4% YTD. Recommended For YouMore Trending NewsSee More »About BEAM StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgBEAM--Beam Therapeutics Inc.Trending AnalysisTrending News